The ransomware claim alleges that the threat actor Lynx targeted VIR, a US-based immunology company, to disrupt their operations and potentially expose sensitive research data. The incident underscores the persistent threats faced by biotech firms in the US. #UnitedStates
Incident Details
Information
- VIR is a ransomware victim.
- The company is based in the United States.
- The threat actor behind the attack is Lynx.
- Vir Biotechnology is a clinical-stage immunology company.
- It focuses on combining immunologic insights with technologies to treat and prevent serious infectious diseases.
- The company was founded in 2016.
- Headquartered in San Francisco, California.
Disclaimer: This post is based on public claims made by the ransomware group "lynx". I cannot confirm the accuracy of the information. However, I would be happy to share any official statement from the affected organization to provide clarification.